Somite just raised. Here's exactly what to do next.
Who to reach, what to say, and why now — on Somite, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Everyone else gives you a piece
Only Fundz delivers all four.
Somite AI secures $47.5 million Series A funding to enhance its AI platform for cell therapy, aiming to revolutionize human regeneration and repair.
Amount Raised
$47.5 Million
Round Type
series a
Description
Somite AI has raised $47.5 million in a Series A funding round to expand its AI-driven platform focused on cell therapy. The funding will support initiatives to leverage AI for human regeneration and repair. CEO Breakstone emphasizes the transformative potential of AI in combating bodily deterioration through innovative cell therapies. Investors are excited about the opportunities this brings for curing diseases.
Related People
Funding Insights
Based on industry dataWatching Somite? See every signal — funding, hires, M&A, contracts, sentiment.
Request a demoChoose your plan